
HIV type 2 subtype A (isolate SBLISY) Gag 313-322, AAVKNWMTQTL
Description
About HIV type 2 subtype A (isolate SBLISY) Gag 313-322, AAVKNWMTQTL
The Human immunodeficiency virus (HIV) type 2 subtype A (isolate SBLISY) Gag polyprotein (gag) Peptide (IEDB: 226820) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Gag polyprotein (gag) Peptide, H-AAVKNWMTQTL-OH (Uniprot: P12450 aa: 313-322) from JPT is produced under strict quality control and quality management.
HIV type 2 subtype A (isolate SBLISY) Gag 313-322, AAVKNWMTQTL - Specifications
- Peptide sequence: H-AAVKNWMTQTL-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): AIDS (HIV)
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for HIV type 2 subtype A (isolate SBLISY) Gag 313-322, AAVKNWMTQTL
References:
Read References with JPT’s Antigen Peptides
HIV type 2 subtype A (isolate SBLISY) Gag 313-322, AAVKNWMTQTL has been described in:
Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination., Sci Transl Med, 2013 (PMID: 24068737)
Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum Stability., Cancer Immunol Res, 2018 (PMID: 29915023)
Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy., Cancer Res, 2005 (PMID: 16024648)
Documentation
Documentation for HIV type 2 subtype A (isolate SBLISY) Gag 313-322, AAVKNWMTQTL
Properties
Properties of HIV type 2 subtype A (isolate SBLISY) Gag 313-322, AAVKNWMTQTL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | AIDS (HIV) |
Layout: | Freeze-dried in glass vial |
Organism: | Human immunodeficiency virus (HIV) |
Protein Name: | Gag polyprotein (gag) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to HIV type 2 subtype A (isolate SBLISY) Gag 313-322, AAVKNWMTQTL
Information | Values |
---|---|
Sequence: | H-AAVKNWMTQTL-OH |
Specifications: | 11mer peptide as TFA salt |